An2 Therapeutics, Inc. · NASDAQ:ANTX
Commodore Capital LP reported a 9.90% stake in An2 Therapeutics, Inc. (Schedule 13G)
Event Mar 9, 2026 · Filed Mar 16, 2026
Commodore Capital LP reported a 9.90% stake in An2 Therapeutics, Inc., 3,697,435 shares, as a passive investor on Mar 9, 2026. Filed Mar 16, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 3,697,435
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 9.90% | 3,697,435 |
| Commodore Capital Master LP | 9.90% | 3,697,435 |
| Robert Egen Atkinson | 9.90% | 3,697,435 |
| Michael Kramarz | 9.90% | 3,697,435 |